Aggressive Nk Cell Leukemia Treatment

Aggressive nk cell leukemia ankl is a highly aggressive disease which has only been recognized as a clinical entity in the last 20 years it is a rare malignancy accounting for less than 1 of all non hodgkin lymphoma in europe and north america being more prevalent in asia and latin america ankl often affects young patients and is characterized by relative resistance.

Aggressive nk cell leukemia treatment.

Large granular lymphocyte lgl leukemia is an indolent lymphoproliferative disorder that belongs to mature t and natural killer nk cell neoplasms and is recognized as cytotoxic t and nk cell lymphomas and leukemia in the 2016 world health organization classification. The cancer occurs in the peripheral blood. However in recent years scientists have developed techniques to better recognize the different types of lymphomas such as ptcl. Aggressive nk cell leukemia also called aggressive nk cell lymphoma or ankl is a very rare type of nhl.

The disease is usually resistant to cytotoxic agents and no treatment has emerged as the standard of care for these patients. Aggressive natural killer leukemia ankl is a rare neoplastic proliferation of mature natural killer nk cells described in the world health organization 2008 with fewer than 200 cases reported in the literature ankl has a distinct geographic distribution with the most prevalence in asians more commonly affecting young to middle aged adults and is almost. 1 two subtypes of chronic lgl proliferation are described t lgl and nk lgl which account for more than 85 and 10 of cases. Currently aggressive nk cell leukemia being a subtype of ptcl is treated similarly to b cell lymphomas.

There is no gender preference with the median age of presentation being in the third decade. Aggressive natural killer cell leukemia ankl or aggressive nk cell leukemia is a very rare and highly aggressive cancer that is mostly observed in adults. Aggressive nk cell leukemia ankl is a rare malignant lymphoproliferative disease of mature nk cell type 1 3 ankl is prevalent among eastern asian populations compared with western countries and develops mainly in the relatively young 4 6 ankl is closely associated with epstein barr virus ebv 7 8 with only 10 of ankl cases negative for ebv. The median overall survival os is less than 2 months.

It is grouped with t cell lymphomas. Which means that the malignant cells are present in the peripheral blood. Ankl develops most often in people from asia central america and south america. Aggressive nk cell leukemia ankl is a rare form of nk cell neoplasm sporadically affecting people from asia and central and south america.

Aggressive nk cell leukemia is a rare malignancy with neoplastic proliferation of natural killer cells.